Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days

5 Biotech Stocks to Buy in 2025 Amid Uncertain Macroenvironment

By Ekta Bagri | July 02, 2025, 9:28 AM

Immunocore Holdings plc ADR

Kiniksa Pharmaceuticals International Plc

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Exelixis, Inc. (EXEL): Free Stock Analysis Report

Alkermes plc (ALKS): Free Stock Analysis Report

Verona Pharma PLC American Depositary Share (VRNA): Free Stock Analysis Report

Kiniksa Pharmaceuticals International, plc (KNSA): Free Stock Analysis Report

Immunocore Holdings PLC Sponsored ADR (IMCR): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Mentioned In This Article

Immunocore Holdings plc ADR

Kiniksa Pharmaceuticals International Plc

Latest News

Sep-04	Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference KNSA GlobeNewswire
Sep-04	IBD Stock Of The Day Exelixis Hits Earnings Snag - And Then Breaks Out EXEL Investor's Business Daily
Sep-02	Cancer Stock Breaks Out To Highs; Key FDA Action On Watch EXEL Investor's Business Daily
Sep-01	Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in September EXEL Business Wire
Sep-01	Immunocore to present at upcoming investor conferences IMCR GlobeNewswire
Aug-31	Exelixis Announces Update on Patent Litigation Trial Appeal with MSN Laboratories EXEL Business Wire
Aug-28	Strong Sales, Earnings Send Exelixis Shares Higher EXEL FX Empire
Aug-24	The Lancet Neurology Publishes Data From Alkermes Positive Vibrance-1 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 1 ALKS Business Wire
Aug-24	Exelixis Owners Keep Getting A Bigger Slice Of A Company In Transition EXEL Trefis
Aug-21	Exelixis, Valaris, and 3 More Stocks See Action From Activist Investors EXEL Barrons.com
Aug-07	Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference KNSA GlobeNewswire
Aug-06	Why This Top-Ranked IBD 50 Stock Just Tumbled On Its Earnings EXEL -7.94% Investor's Business Daily
Aug-06	Immunocore Holdings PLC (IMCR) (Q2 2026) Earnings Call Highlights: Kimtrak Growth and Pipeline ... IMCR GuruFocus.com
Aug-06	The Race to Come Up With the Next Big Sleep Drug ALKS The Wall Street Journal
Aug-06	Immunocore Holdings PLC (IMCR) (Q2 2026) Earnings Call Highlights: Strong Kimtrak Growth and ... IMCR GuruFocus.com

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)